Tandem Diabetes Care
Manufacturing · California, United States · 2,400 Employees
View Company Info for Free
About
Headquarters
12400 High Bluff Dr, San Diego, California, 921...Phone Number
(858) 366-6900Website
www.tandemdiabetes.comRevenue
$770 MillionStock Symbol
TNDMIndustry
Most Recent Scoops
Highlights
$884.8M
Total Funding Amount
$250M
Most Recent Funding Amount
13
Number of Funding Rounds
Who is Tandem Diabetes Care
Tandem Diabetes Care Org Chart
Is Tandem Diabetes Care your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tandem Diabetes Care recently announced quarterly report
Funding: Get notified immidiatlly once Tandem Diabetes Care has new funding data
Congratulate Masked Content for being promoted to Masked Content at Tandem Diabetes Care
Tandem Diabetes Care, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Tandem Diabetes Care is spiking on competitors!
Check if Tandem Diabetes Care has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Tandem Diabetes Care launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tandem Diabetes Care had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Tandem Diabetes Care
Compare insights from companies similar to Tandem Diabetes Care, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Tandem Diabetes Care
Tandem Diabetes Care financials insights
Gather financial insights about Tandem Diabetes Care, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Tandem Diabetes Care Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Tandem Diabetes Care Tech Stack
A closer look at the technologies used by Tandem Diabetes Care
Most Recent Scoops
Tandem Diabetes Care News & Media
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2024 and increased sales guidance for the year ending December 31, 2024. Third Quarter 2024 Highlights Worldwide GAAP sales increased 31 percent to $244.0 million compared to third quarter 2023; worldwide non-GAAP sales(1) increased 25 percent to $242.9 million compared to third quarter 2023. GrTandem Diabetes Care Announces Upcoming Conference Participation
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: UBS Global Healthcare Conference on Thursday, November 14, 2024 at 11:45am Eastern Time (8:45am Pacific Time), Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024 at 11:30am Eastern Time (8:30am Pacific Time), Jefferies London HealthcareTandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2024 results after the financial markets close on Wednesday, November 6, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2024 financial and operating results. A live webcast of the call will beTandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company’s Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the European Union (EU). “High satisfaction and quality of life benefits were recently shown in a clinical study using
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Tandem Diabetes Care
Founded in 2006 and headquartered in San Diego, California, Tandem Diabetes Care is a company that manufactures medical devices that help measure blood sugar in the blood of diabetic patients.... Read More